What’s been happening at the EPO and at the UPC in this increasingly important technology space since the UPC started operations in 2023, including the latest trends and statistics and the interplay between the two supra-national institutions – and practical MedTech considerations for the savvy in-house patent counsel or overseas private-practice patent practitioner.
In this short and fast-paced webinar, K&S European patent attorney & UPC representative Caelia Bryn-Jacobsen is joined by eminent guest Graham Burnett-Hall (UK solicitor advocate and UPC Representative) of Shoosmiths to take a deep look into the MedTech patent litigation scene in Europe since the start of the UPC in June 2023.
- Which patents have been or are being litigated, and by whom?
- Is litigation predominantly happening before the EPO, at the UPC – or in parallel?
- Do national courts still play a role?
- How to exploit all these litigation fora to the best advantage?
Find the answers to these and many more questions, as well as the latest litigation statistics, trends, strategies and outcomes in this commercially important technology field, which is expected to be worth hundreds of billions USD by 2030, in Europe.
The webinar will be chaired by Dr Marco Morbidini, EPA, UPC Representative & Partner of Kilburn & Strode LLP, also a member of the dedicated K&S MedTech team.
We hope you can join us!